The table below is a review of notable updates that occurred in January 2025 for investigational products in development.

Viking Therapeutics, Inc. ("Viking") (NASDAQ: VKTX), a clinical-stage biopharmaceutical company focused on the development of novel therapies for metabolic and endocrine disorders, today announced its ...

Conference call scheduled for 4:30 p.m. ET today Initiation of Phase 3 Studies for Subcutaneous VK2735 for Obesity Planned for 2Q25 Phase 2 VENTURE-Oral Dosing Trial ...

The short answer is yes, orange juice is high in vitamins and minerals. But it can become less nutritious with lots of added ...

According to the photo's caption, pictured here are "A Rockwitz (312lbs), comedian Eddie Carvey (250lbs), David Burns (475lbs ...

Following completion of the VENTURE study, Viking requested and was granted a Type C meeting with the FDA to ... by genetic mutations that disable the function of a peroxisomal transporter of ...

Apolipoprotein A-I mimetic peptides are amphipathic alpha-helix peptides that display similar functions to apolipoprotein A-I ... 5´- ACTGTCCAATCAGGCATAGCG-. 3´. C-C chemokine receptor type 2 (CCR2) ...

ZUG, Switzerland and BOSTON, Feb. 11, 2025 (GLOBE NEWSWIRE) -- CRISPR Therapeutics (Nasdaq: CRSP), a biopharmaceutical company focused on creating transformative gene-based medicines for serious ...

Understand what the results of your cholesterol test mean and find out what might be causing your high cholesterol.

Previous studies have highlighted its adverse effects on reproductive function, as BPA exposure reduces testosterone ... and testosterone synthesis in TM3 cells and mice via Apolipoprotein A1 ...

Atherosclerotic cardiovascular disease is a major health concern worldwide and requires effective preventive measures. Lp(a) (lipoprotein [a]) has recently garnered attention as an independent risk ...